MA52362A - Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque - Google Patents

Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque

Info

Publication number
MA52362A
MA52362A MA052362A MA52362A MA52362A MA 52362 A MA52362 A MA 52362A MA 052362 A MA052362 A MA 052362A MA 52362 A MA52362 A MA 52362A MA 52362 A MA52362 A MA 52362A
Authority
MA
Morocco
Prior art keywords
butoxylcarbonyl
piperidine
tert
preparation
benzoic acid
Prior art date
Application number
MA052362A
Other languages
English (en)
Inventor
Dimitar Filipov
Miroslav Rapta
Original Assignee
Theravance Biopharma R&D Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Biopharma R&D Ip Llc filed Critical Theravance Biopharma R&D Ip Llc
Publication of MA52362A publication Critical patent/MA52362A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA052362A 2018-06-01 2019-05-29 Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque MA52362A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862679586P 2018-06-01 2018-06-01

Publications (1)

Publication Number Publication Date
MA52362A true MA52362A (fr) 2021-03-03

Family

ID=66912982

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052362A MA52362A (fr) 2018-06-01 2019-05-29 Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque

Country Status (7)

Country Link
US (1) US10640467B2 (fr)
EP (1) EP3784655B1 (fr)
JP (1) JP7252978B2 (fr)
CN (1) CN112204007B (fr)
ES (1) ES2960492T3 (fr)
MA (1) MA52362A (fr)
WO (1) WO2019232010A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118973577A (zh) 2022-03-28 2024-11-15 施万生物制药研发Ip有限责任公司 用于治疗多系统萎缩症的阿普罗西汀
CN119841766B (zh) * 2025-01-16 2025-12-12 上海凌凯科技股份有限公司 一种戊二酰亚胺类化合物的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2891066A (en) 1957-08-14 1959-06-16 Parke Davis & Co 4,o-substituted phenyl 1 alkanol piperidines and esters thereof
KR960705808A (ko) * 1993-11-09 1996-11-08 조셉 에프. 디프리마 성장 호르몬의 방출을 촉진시키는 피페리딘, 피롤리딘 및 헥사하이드로-1H-아제핀(Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone)
NZ592543A (en) 2008-11-14 2013-02-22 Theravance Inc 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
ES3000460T3 (en) 2016-08-30 2025-02-28 Theravance Biopharma R&D Ip Llc Ampreloxetine for use in the treatment of neurogenic orthostatic hypotension

Also Published As

Publication number Publication date
JP7252978B2 (ja) 2023-04-05
US20190367455A1 (en) 2019-12-05
WO2019232010A1 (fr) 2019-12-05
US10640467B2 (en) 2020-05-05
CN112204007A (zh) 2021-01-08
JP2021526142A (ja) 2021-09-30
ES2960492T3 (es) 2024-03-05
EP3784655A1 (fr) 2021-03-03
CN112204007B (zh) 2023-06-20
EP3784655B1 (fr) 2023-10-04
EP3784655C0 (fr) 2023-10-04

Similar Documents

Publication Publication Date Title
EP3746564A4 (fr) Procédé d'amplification d'acide nucléique
EP3622080C0 (fr) Procédés améliorés pour la production d'isobutène à partir d'acide 3-méthylcrotonique
EP3854403C0 (fr) Utilisation de composés d'aminopropionate substitués dans le traitement de l'infection sars-cov-2
MA41513A (fr) Procédé de distillation pour la production d'acide acrylique
EP3512947A4 (fr) Procédés de préparation d'échantillon d'acide nucléique
EP3903785A4 (fr) Cristal de composé d'acide pyrophosphorique
BR112013016982A2 (pt) formas polimórficas de ácido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acético e usos destes
EP3481819A4 (fr) Composés et utilisation de ces derniers pour réduire les niveaux d'acide urique
FR3049601B1 (fr) Procede ameliore de production d'acide (meth)acrylique
MA55917A (fr) Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie
EP3907289A4 (fr) Estérase d'acide chrysanthémique modifiée
EP3808732A4 (fr) Procédé de préparation d'isocyanates aliphatiques
EP3564208A4 (fr) Procédé de préparation d'un dérivé d'acide malonique 2-(cyclohexénylène) et son utilisation
EP3733648A4 (fr) Procédé de préparation d'acide 5r-benzyloxyaminopipéridin-2s-carboxylique ou d'un dérivé de celui-ci
MA56055A (fr) Procédés de préparation d'acide 5-bromo-2-(3chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylique
EP3813816C0 (fr) Utilisation de l'acide (s)-3-amino-4-(difluorométhylényl)cyclopent-1-ène-1-carboxylique et de composés apparentés, de l'acide (1s,3s)-3-amino-4-(difluorométhylidène)cyclopentane-1-carboxylique dans le traitement de le syndrome de l'x fragile ou le syndrome de tremblement/ataxie associé à l'x fragile
MA52362A (fr) Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque
EP3940053A4 (fr) Procédé d'amplification d'acide nucléique
HUE063674T2 (hu) Eljárás N-(amino-imino-metil)-2-aminoetánsav (III) metastabil kristálymódosulatának elõállítására
EP3643311A4 (fr) Composé d'acide tétramique 4-oxo-alkylé, son procédé de préparation et son utilisation
EP3931347A4 (fr) Procédé amélioré de préparation d'échantillons cliniques pour amplification d'acide nucléique
EP3889572A4 (fr) Procédé de préparation d'échantillon
EP3476943A4 (fr) Procédé de fabrication d'acide polyhydroxyalcanoïque
DK4132915T3 (da) Substituerede isophtalsyrediamider
EP3995535A4 (fr) Composition d'ester d'acide phtalique